Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures. (2016)

First Author: Ye Z
Attributed to:  Innovative Technologies for Stratified and Experimental Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/hbm.23087

PubMed Identifier: 26757216

Publication URI: http://europepmc.org/abstract/MED/26757216

Type: Journal Article/Review

Volume: 37

Parent Publication: Human brain mapping

Issue: 3

ISSN: 1065-9471